¼¼°èÀÇ Ç츶ÅäÅ©¸´ °Ë»ç ±â±â ½ÃÀå º¸°í¼­(2025³â)
Hematocrit Test Devices Global Market Report 2025
»óǰÄÚµå : 1704508
¸®¼­Ä¡»ç : The Business Research Company
¹ßÇàÀÏ : On Demand Report
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 200 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,490 £Ü 6,151,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,490 £Ü 8,891,000
PDF (Site License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷ÀåÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,490 £Ü 11,632,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
¤± º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼Û±âÀÏÀº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

Ç츶ÅäÅ©¸´ °Ë»ç ±â±â ½ÃÀå ±Ô¸ð´Â ÇâÈÄ ¸î ³â µ¿¾È °­·ÂÇÑ ¼ºÀå¼¼¸¦ º¸ÀÏ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2029³â¿¡´Â ¿¬Æò±Õ 6.5%ÀÇ CAGR·Î 63¾ï 7,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¿¹Ãø ±â°£ µ¿¾ÈÀÇ ¼ºÀåÀº ºóÇ÷ À¯º´·ü Áõ°¡, Ç÷¾× Áúȯ »ç·Ê Áõ°¡, ³ëÀÎ Àα¸ Áõ°¡, °Ç°­ ¹× ÇÇÆ®´Ï½º¿¡ ´ëÇÑ °ü½É Áõ°¡, ½ÉÇ÷°ü Áø´Ü Àåºñ¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¿¡ ±âÀÎÇÏ´Â °ÍÀ¸·Î ÃßÁ¤µË´Ï´Ù. ¿¹Ãø ±â°£ µ¿¾È ÁÖ¿ä µ¿ÇâÀ¸·Î´Â ÃÖ÷´Ü ¼Ö·ç¼Ç µµÀÔ, ÀÇÇÐ ºÐ¾ßÀÇ ±â¼ú ¹ßÀü, È¿À²ÀûÀ̰í Çõ½ÅÀûÀÎ ½ÅÁ¦Ç° °³¹ß, Ç츶ÅäÅ©¸´ °Ë»ç ±â¼ú °³¹ß, ÇコÄÉ¾î ºÐ¾ßÀÇ ¹ßÀü µîÀ» µé ¼ö ÀÖ½À´Ï´Ù.

Ç÷¾× Áúȯ »ç·ÊÀÇ Áõ°¡´Â ÇâÈÄ ¸î ³â µ¿¾È Ç츶ÅäÅ©¸´ °Ë»ç ±â±â ½ÃÀåÀÇ ¼ºÀåÀ» ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. Ç÷¾× Áúȯ¿¡´Â ÀûÇ÷±¸, ¹éÇ÷±¸, Ç÷¼ÒÆÇ, Ç÷Àå µî ÀÎü Ç÷¾×ÀÇ ´Ù¾çÇÑ ¼ººÐ¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â ÁúȯÀÌ Æ÷ÇԵ˴ϴÙ. ÀÌ·¯ÇÑ ÁúȯÀº À¯ÀüÀû ¿äÀÎ, ȯ°æ¿À¿°, »ýȰ½À°ü º¯È­ µîÀÇ º¹ÇÕÀûÀÎ ¿äÀÎÀ¸·Î ÀÎÇØ ´õ¿í ÈçÇØÁö°í ÀÖ½À´Ï´Ù. Ç츶ÅäÅ©¸´ ÃøÁ¤±â´Â ÀüÇ÷ ³» ÀûÇ÷±¸ ¿ëÀû·üÀ» ÃøÁ¤ÇÏ´Â µ¥ Áß¿äÇÑ ¿ªÇÒÀ» Çϸç, ȯÀÚÀÇ Ç÷¾×ÇÐÀû °Ç°­ »óÅ¿¡ ´ëÇÑ ÇʼöÀûÀÎ ÀλçÀÌÆ®¸¦ Á¦°øÇÕ´Ï´Ù. ¿¹¸¦ µé¾î, ¹Ì±¹ ¾ÏÇùȸ°¡ 2024³â 1¿ù¿¡ ¹ßÇ¥ÇÑ º¸°í¼­¿¡ µû¸£¸é, 2024³â ¹Ì±¹ ³» ¹éÇ÷º´ ½Å±Ô ȯÀÚ ¼ö´Â ¾à 6¸¸ 2,770¸í, »ç¸ÁÀÚ ¼ö´Â 2¸¸ 3,670¸íÀ¸·Î ¿¹»óÇϰí ÀÖ½À´Ï´Ù. ÀÌ Áß ±Þ¼º °ñ¼ö¼º ¹éÇ÷º´(AML)Àº ¾à 20,800¸íÀÌ »õ·Î ¹ßº´ÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ÁÖ·Î ¼ºÀΠȯÀÚ°¡ ¹ßº´Çϰí, ¾à 1,220¸íÀÌ AML·Î ÀÎÇØ »ç¸ÁÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌó·³ Ç÷¾× ÁúȯÀÇ Áõ°¡°¡ Ç츶ÅäÅ©¸´ °Ë»ç ±â±â ½ÃÀåÀÇ ¼ºÀåÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

Ç츶ÅäÅ©¸´ °Ë»ç ±â±â ½ÃÀåÀÇ ÁÖ¿ä ¾÷üµéÀº ÀüÇ÷±¸°è»ê(CBC) Ç÷¾×ÇÐ ºÐ¼®±â µî Ç÷¾× ¼¼Æ÷¿¡ ´ëÇÑ Á¤·®Àû, Á¤¼ºÀû Á¤º¸¸¦ Á¦°øÇÏ´Â Á¦Ç°±ºÀ» Çõ½ÅÀûÀ¸·Î °³¹ßÇϰí ÀÖ½À´Ï´Ù. ÀüÇ÷±¸°è¼ö(CBC) Ç÷¾×ÇÐ ºÐ¼®±â´Â ÀûÇ÷±¸(RBC), ¹éÇ÷±¸(WBC), Ç÷¼ÒÆÇÀ» Æ÷ÇÔÇÑ Ç÷¾×ÀÇ ´Ù¾çÇÑ ¼ººÐÀ» ÃøÁ¤ ¹× ºÐ¼®ÇÏ´Â µ¥ »ç¿ëµÇ´Â ÀÚµ¿ ÀåÄ¡ÀÔ´Ï´Ù. ¿¹¸¦ µé¾î, 2022³â 3¿ù Áß±¹ ÀÇ·á±â±â ȸ»çÀÎ Mindray Medical International Limited´Â BC-700 Ç÷±¸ °è¼ö ÀåÄ¡ ½Ã¸®Á ¹ßÇ¥Çß½À´Ï´Ù. ÀÌ ½Ã¸®Áî´Â ÀüÇ÷±¸°è»ê(CBC)°ú ÀûÇ÷±¸Ä§°­¼Óµµ(ESR) °Ë»ç¸¦ ¸ðµÎ ¾Æ¿ì¸£¸ç, ÇÁ¸®¹Ì¾ö Á¦Ç°¿¡ °¡±î¿î °í±Þ Áø´Ü±â¼ú·Î Áß±Ô¸ð °Ë»ç½Ç¿¡ ´ëÀÀÇϸç, BC-720, BC-760, BC-780 µîÀÇ ¸ðµ¨À» Æ÷ÇÔÇÑ BC-700 ½Ã¸®Áî´Â °í±ÞÇüÀÎ BC-6000 SF Cube ±â¼úÀº Çü±¤°ú 2°¢ ·¹ÀÌÀú »ê¶õ ½ÅÈ£¸¦ Ȱ¿ëÇÏ¿© Ç¥Àû ¼¼Æ÷ÀÇ 3Â÷¿ø ºÐ¼®À» °¡´ÉÄÉ ÇÏ´Â ¸¶ÀÎµå ·¹ÀÌÀÇ SF Cube 3D ºÐ¼® ±â¼úÀ» žÀçÇϰí ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ½ÃÀå Æ¯Â¡

Á¦3Àå ½ÃÀå µ¿Çâ°ú Àü·«

Á¦4Àå ½ÃÀå - ±Ý¸®, ÀÎÇ÷¹À̼Ç, ÁöÁ¤ÇÐ, ½ÅÁ¾ Äڷγª¹ÙÀÌ·¯½º °¨¿°Áõ, ±×¸®°í °æ±âȸº¹ÀÌ ½ÃÀå¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» Æ÷ÇÔÇÑ °Å½Ã°æÁ¦ ½Ã³ª¸®¿À

Á¦5Àå ¼¼°èÀÇ ¼ºÀå ºÐ¼®°ú Àü·« ºÐ¼® ÇÁ·¹ÀÓ¿öÅ©

Á¦6Àå ½ÃÀå ¼¼ºÐÈ­

Á¦7Àå Áö¿ªº°¡¤±¹°¡º° ºÐ¼®

Á¦8Àå ¾Æ½Ã¾ÆÅÂÆò¾ç ½ÃÀå

Á¦9Àå Áß±¹ ½ÃÀå

Á¦10Àå Àεµ ½ÃÀå

Á¦11Àå ÀϺ» ½ÃÀå

Á¦12Àå È£ÁÖ ½ÃÀå

Á¦13Àå Àεµ³×½Ã¾Æ ½ÃÀå

Á¦14Àå Çѱ¹ ½ÃÀå

Á¦15Àå ¼­À¯·´ ½ÃÀå

Á¦16Àå ¿µ±¹ ½ÃÀå

Á¦17Àå µ¶ÀÏ ½ÃÀå

Á¦18Àå ÇÁ¶û½º ½ÃÀå

Á¦19Àå ÀÌÅ»¸®¾Æ ½ÃÀå

Á¦20Àå ½ºÆäÀÎ ½ÃÀå

Á¦21Àå µ¿À¯·´ ½ÃÀå

Á¦22Àå ·¯½Ã¾Æ ½ÃÀå

Á¦23Àå ºÏ¹Ì ½ÃÀå

Á¦24Àå ¹Ì±¹ ½ÃÀå

Á¦25Àå ij³ª´Ù ½ÃÀå

Á¦26Àå ³²¹Ì ½ÃÀå

Á¦27Àå ºê¶óÁú ½ÃÀå

Á¦28Àå Áßµ¿ ½ÃÀå

Á¦29Àå ¾ÆÇÁ¸®Ä« ½ÃÀå

Á¦30Àå °æÀï ±¸µµ¿Í ±â¾÷ °³¿ä

Á¦31Àå ±âŸ ÁÖ¿ä ±â¾÷°ú Çõ½ÅÀû ±â¾÷

Á¦32Àå ¼¼°èÀÇ ½ÃÀå °æÀï º¥Ä¡¸¶Å·°ú ´ë½Ãº¸µå

Á¦33Àå ÁÖ¿ä ÀμöÇÕº´

Á¦34Àå ÃÖ±ÙÀÇ ½ÃÀå µ¿Çâ

Á¦35Àå ½ÃÀå ÀáÀç·ÂÀÌ ³ôÀº ±¹°¡, ºÎ¹®, Àü·«

Á¦36Àå ºÎ·Ï

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Hematocrit test devices are medical instruments utilized to measure the percentage of red blood cells (RBCs) in a person's total blood volume. These devices serve various purposes, including monitoring chronic conditions, preoperative assessments, detecting blood doping, screening blood donors, managing emergencies, and conducting research and clinical trials.

The primary types of hematocrit test devices include hematocrit test meters, hematocrit test analyzers, and reagents and consumables. A hematocrit (HCT) test meter is a point-of-care device employed to measure the percentage of red blood cells in whole blood. It finds applications in conditions such as anemia, polycythemia vera, congenital heart diseases, among others, and is utilized by various end-users, including hospitals and ambulatory surgical centers, clinics, diagnostic and pathology labs, among others.

The hematocrit test devices market research report is one of a series of new reports from The Business Research Company that provides hematocrit test devices market statistics, including hematocrit test devices industry global market size, regional shares, competitors with a hematocrit test devices market share, detailed hematocrit test devices market segments, market trends and opportunities, and any further data you may need to thrive in the hematocrit test devices industry. This hematocrit test devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The hematocrit test devices market size has grown strongly in recent years. It will grow from $4.63 billion in 2024 to $4.95 billion in 2025 at a compound annual growth rate (CAGR) of 6.9%. The growth in the historic period can be attributed to a rise in awareness regarding anemia, lack of iron and vitamins, increased incidence of chronic illnesses, the surge in government funding, and increase in the population.

The hematocrit test devices market size is expected to see strong growth in the next few years. It will grow to $6.37 billion in 2029 at a compound annual growth rate (CAGR) of 6.5%. The growth in the forecast period can be attributed to increasing prevalence of anemia, growing cases of blood disorders, rise in geriatric population, growth in focus on health and fitness, and widening need for cardiovascular diagnostic equipment. Major trends in the forecast period include the introduction of cutting-edge solutions, advancement of technology in medical science, creation of new efficient and innovative products, technical developments in hematocrit testing, and advancements in the healthcare sector.

The increasing instances of blood disorders are anticipated to drive the expansion of the hematocrit test devices market in the coming years. Blood disorders encompass conditions affecting the various components of human blood, such as red blood cells, white blood cells, platelets, and plasma. These disorders are becoming more prevalent due to a combination of factors including genetic factors, environmental pollution, and changes in lifestyle. Hematocrit test devices play a vital role in measuring the volume percentage of red blood cells in whole blood, offering essential insights into the patient's hematological well-being. For example, a report published by the American Cancer Society in January 2024 projects approximately 62,770 new cases of leukemia in the United States for 2024, leading to an estimated 23,670 deaths. Among these cases, around 20,800 new instances of acute myeloid leukemia (AML) are expected, predominantly affecting adults, with approximately 11,220 deaths attributed to AML, primarily occurring in adult patients. Thus, the rising occurrences of blood disorders are stimulating the growth of the hematocrit test devices market.

Leading companies in the hematocrit test device market are innovating their product offerings, such as complete blood count (CBC) hematology analyzers, to deliver both quantitative and qualitative information about blood cells. A complete blood count (CBC) hematology analyzer is an automated instrument utilized to measure and analyze various components of blood, including red blood cells (RBCs), white blood cells (WBCs), and platelets. For instance, in March 2022, Mindray Medical International Limited, a China-based medical device company, introduced the BC-700 hematology analyzer series. This series encompasses both complete blood count (CBC) and erythrocyte sedimentation rate (ESR) tests, catering to medium-volume laboratories with advanced diagnostic technologies akin to premium products. The BC-700 Series, including models such as BC-720, BC-760, and BC-780, is a more compact iteration of the high-end BC-6000 Series, featuring Mindray's SF Cube 3D analysis technology. Leveraging fluorescence and bi-angular laser scatter signals, the SF Cube technology enables three-dimensional analysis of target cells.

In June 2023, Mars Incorporated, a US-based packaged food products manufacturer, acquired Heska Corporation for $1.3 billion. With this acquisition, Heska now operates under Mars Petcare's Science & Diagnostics division, expanding its reach in diagnostics and technology. The integration facilitates accelerated research and development efforts while enhancing global access to pet healthcare solutions. Heska Corporation specializes in manufacturing hematocrit test devices.

Major companies operating in the hematocrit test devices market are F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Bayer AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthcare GmbH, Becton, Dickinson and Company (BD), Terumo Corporation, Beckman Coulter Inc., Mindray Medical International Limited, bioMerieux SA, Sysmex Corporation, Horiba Ltd., Nihon Kohden Corporation, Erba Mannheim, Heska Corporation, EKF Diagnostics Holding Plc., Nova Biomedical Corporation, Boule Diagnostics AB, Stanbio Laboratory Lp, Drucker Diagnostics, A. Menarini Diagnostics Srl, Sensa Core, Mikroscan Technologies Inc.

North America was the largest region in the hematocrit test devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hematocrit test devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the hematocrit test devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The hematocrit test devices market consists of sales of hematocrit centrifuges, test strips, capillary transfer tubes, and adapter kits. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Hematocrit Test Devices Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on hematocrit test devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for hematocrit test devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The hematocrit test devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Hematocrit Test Devices Market Characteristics

3. Hematocrit Test Devices Market Trends And Strategies

4. Hematocrit Test Devices Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Hematocrit Test Devices Growth Analysis And Strategic Analysis Framework

6. Hematocrit Test Devices Market Segmentation

7. Hematocrit Test Devices Market Regional And Country Analysis

8. Asia-Pacific Hematocrit Test Devices Market

9. China Hematocrit Test Devices Market

10. India Hematocrit Test Devices Market

11. Japan Hematocrit Test Devices Market

12. Australia Hematocrit Test Devices Market

13. Indonesia Hematocrit Test Devices Market

14. South Korea Hematocrit Test Devices Market

15. Western Europe Hematocrit Test Devices Market

16. UK Hematocrit Test Devices Market

17. Germany Hematocrit Test Devices Market

18. France Hematocrit Test Devices Market

19. Italy Hematocrit Test Devices Market

20. Spain Hematocrit Test Devices Market

21. Eastern Europe Hematocrit Test Devices Market

22. Russia Hematocrit Test Devices Market

23. North America Hematocrit Test Devices Market

24. USA Hematocrit Test Devices Market

25. Canada Hematocrit Test Devices Market

26. South America Hematocrit Test Devices Market

27. Brazil Hematocrit Test Devices Market

28. Middle East Hematocrit Test Devices Market

29. Africa Hematocrit Test Devices Market

30. Hematocrit Test Devices Market Competitive Landscape And Company Profiles

31. Hematocrit Test Devices Market Other Major And Innovative Companies

32. Global Hematocrit Test Devices Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Hematocrit Test Devices Market

34. Recent Developments In The Hematocrit Test Devices Market

35. Hematocrit Test Devices Market High Potential Countries, Segments and Strategies

36. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â